Primary endpoint discrepancies were found in one in ten clinical drug trials. Results of an inception cohort study

Improvement in completeness of reporting is still needed, especially among investigator-initiated trials and non-RCTs. To eliminate undisclosed discrepancies, trial protocols should be available in the public domain at the same time when the trial is published.